We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Proteome Sciences Plc | LSE:PRM | London | Ordinary Share | GB0003104196 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.25 | 2.50 | 4.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 7.78M | 1.33M | 0.0045 | 7.22 | 9.59M |
TIDMPRM
RNS Number : 3690T
Proteome Sciences PLC
04 January 2017
Proteome Sciences plc
(the "Company")
Holdings in Company and PDMR Shareholding
Proteome Sciences plc (AIM:PRM) received notification from Vulpes Life Sciences Fund ("Vulpes"), of which Martin Diggle, a non-executive director of the Company, is a director and partner, that today, it purchased 105,590 ordinary shares of 1 pence each ("Ordinary Shares") at 5.5 pence per Ordinary Share (the "Transaction"). Following the Transaction, Vulpes (and Mr Diggle) have a beneficial interest in 53,943,715 Ordinary Shares, representing approximately 18.33% of the current issued share capital of the Company.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1. Details of the person discharging managerial responsibilities / person closely associated --- ----------------------------------------------------------------- a) Name Vulpes Life Sciences Fund --- ------------------------------- -------------------------------- 2. Reason for the Notification --- ----------------------------------------------------------------- a) Position/status Martin Diggle, non-executive director of the Company is a director and partner of Vulpes Life Sciences Fund --- ------------------------------- -------------------------------- b) Initial notification/Amendment Initial notification --- ------------------------------- -------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ----------------------------------------------------------------- a) Name Proteome Sciences plc --- ------------------------------- -------------------------------- b) LEI n/a --- ------------------------------- -------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ----------------------------------------------------------------- a) Description of Ordinary Shares of 1p each the Financial instrument, type of instrument --- Identification GB0003104196 code --- ------------------------------- -------------------------------- b) Nature of the Purchase of Ordinary Shares transaction --- ------------------------------- -------------------------------- c) Price(s) and Price(s) Volume(s) volume(s) 04 January 2017 --------- ---------- 5.5p 105,590 --------- ---------- --- ------------------------------- -------------------------------- d) Aggregated information: * Aggregated volume 105,590 Ordinary Shares of 1 pence each purchased at an average price of 5.5 pence * Price per Ordinary Share --- ------------------------------- -------------------------------- e) Date of the transaction 04 January 2017 --- ------------------------------- -------------------------------- f) Place of the London Stock Exchange, AIM transaction Market (XLON) --- ------------------------------- --------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBLGDBSXGBGRS
(END) Dow Jones Newswires
January 04, 2017 11:36 ET (16:36 GMT)
1 Year Proteome Sciences Chart |
1 Month Proteome Sciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions